FRC
FRC Logo
CommunityMarkets
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileThe Cooper Companies, Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
COO
The Cooper Companies, Inc. Stock AnalysisComprehensive stock analysis for The Cooper Companies, Inc. (COO) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisCOO
COO
The Cooper Companies, Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
COO
  1. Home
  2. Stocks
  3. The Cooper Companies, Inc.

The Cooper Companies, Inc.

🇺🇸COO•NASDAQ

The Cooper Companies, Inc.

🇺🇸COO•NASDAQ
Market cap
$11.77B
Sentiment

Your view on COO

Mkt Cap
$11.77B
Sentiment
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About The Cooper Companies, Inc.

Industry
Medical - Instruments & Supplies
Sector
Healthcare
CEO
Albert G. White III
Headquarters
6101 Bollinger Canyon Road, San Ramon, CA, US
Industry
Medical - Instruments & Supplies
Sector
Healthcare
CEO
Albert G. White III
Headquarters
6101 Bollinger Canyon Road, San Ramon, CA, US
Description

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical.

The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific.

The CooperSurgical segment focuses on family and women's health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide.

It offers surgical and office products, including PARAGARD, uterine manipulators, retractors, closure products, point of care products, LEEP products, endosee, and illuminate and fetal pillows; fertility products and services, such as fertility consumables and equipment, and embryo options and preimplantation genetic testing.

The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

Financial Data

Stock Data

Price chart, volume, and trading data.

What moved it

FRC Fair Value Algorithm

What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.

About this section

Fair value for The Cooper Companies, Inc. from FRC's valuation model, read against the market price. COO last traded at $61.88, 21.2× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for The Cooper Companies, Inc.. Starting points for The Cooper Companies, Inc.: P/E 21.2, EPS $2.95, beta 0.82 — an Medical - Instruments & Supplies name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for The Cooper Companies, Inc.. The Cooper Companies, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for The Cooper Companies, Inc.. Trailing twelve-month EPS for The Cooper Companies, Inc. stands at $2.95. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Third partyAs of Nov 18, 2026 · USD

Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.

Current price

—

live quote

Analysts' target

$65.11

average of 9 firms, last 12 months

 

$65.11

Low $59.00

Median $61.00

High $75.00

 

Analyst Ratings

Hold15 firms, last 12 months
  • Strong Buy0
  • Buy5
  • Hold9
  • Sell1
  • Strong Sell0

Earnings Estimate

EPSCurrent QtrOct 2026Next QtrJan 2027Current YearFY Oct 2026Next YearFY Oct 2027
Avg. estimate$1.07$1.10$4.53$4.68
Low estimate$1.06$1.06$4.52$4.54
High estimate$1.09$1.11$4.54$4.87
No. of analysts1171111
Year-ago EPS$1.15$1.10$1.871—
Growth-7.1%-0.4%——

1Year-ago EPS includes one-time items; growth not shown.

Revenue Estimate

RevenueCurrent QtrOct 2026Next QtrJan 2027Current YearFY Oct 2026Next YearFY Oct 2027
Avg. estimate$1.07B$1.05B$4.24B$4.41B
Low estimate$1.05B$1.03B$4.18B$4.36B
High estimate$1.08B$1.07B$4.25B$4.45B
No. of analysts1051313
Year-ago revenue$1.07B$1.02B$4.09B—
Growth+0.3%+2.7%+3.6%—
Recent analyst actions15 rating and price-target changes, latest Oct 6, 2026 — with the analyst, firm and source

Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep from StreetInsider, Benzinga, Pulse 2.0; as of Nov 18, 2026. Not FRC research or a recommendation.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for The Cooper Companies, Inc.. The Cooper Companies, Inc. has reported as a listed company since 1983. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold COO19 companies · 8 funds
Compare COO with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis

Peer companies

Market cap

  • ALCAlcon Inc.Medical - Specialties$35.4B
  • BLCOBausch + Lomb CorporationMedical - Instruments & Supplies$7.5B
  • ESLOYEssilorLuxottica S.A.Medical - Instruments & Supplies$129.8B
  • GKOSGlaukos CorporationMedical - Devices$14.5B
  • HOCPFHOYA CorporationMedical - Instruments & Supplies$64.6B
  • LNSRLENSAR, Inc.Medical - Devices$65M
  • STAASTAAR Surgical CompanyMedical - Instruments & Supplies$1.3B

More Medical - Instruments & Supplies companies

  • MHUAFMeihua International Medical Technologies Co., Ltd.OTC$6M
  • MLSSMilestone Scientific Inc.AMEX$27M
  • MMSIMerit Medical Systems, Inc.NASDAQ$5.2B
  • NAN.AXNanosonics LimitedASX
  • NEPHNephros, Inc.NASDAQ$33M
  • NNCSFNanosonics LimitedOTC$698M
  • NNNNAnbio Biotechnology Class A Ordinary SharesNASDAQ$170M
  • NPRRFNipro CorporationOTC$1.3B
  • NVSTEnvista Holdings CorpNYSE$3.9B
  • NXGLNEXGEL, Inc.NASDAQ$2M
  • NXGLWNEXGEL, Inc.NASDAQ$504,035
  • OJSYOJsys, Inc.OTC$454,285

ETFs holding The Cooper Companies, Inc.

% of the fund

  • VOOVanguard S&P 500 ETF$1.0T in assets0.02%
  • VTIVanguard Total Stock Market ETF$689.2B in assets0.02%
  • VBVanguard Small-Cap ETF$76.9B in assets0.14%
  • RSPInvesco S&P 500 Equal Weight ETF$101.8B in assets0.19%
  • EQTYKovitz Core Equity ETF$1.4B in assets2.50%
  • FXHFirst Trust Health Care AlphaDEX Fund$1.2B in assets1.98%
  • BASVBrown Advisory Sustainable Value ETF$434M in assets1.91%
  • SMOTVanEck Morningstar SMID Moat ETF$327M in assets1.16%

Largest holders first, then the funds most concentrated in COO.

Open Comparable Analysis
Ownership & News

Institutional Ownership

Which funds and firms own the stock.

About this section

Which institutions hold The Cooper Companies, Inc., and how their positions are changing. At a $11.77B market value, institutional positions materially move The Cooper Companies, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.

Insider Trading

Recent buying and selling by company executives.

About this section

Buying and selling by The Cooper Companies, Inc. executives and directors. Shares of The Cooper Companies, Inc. have traded between $61.78 and $106.63 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

About this section

U.S. Senate disclosures naming The Cooper Companies, Inc.. The Cooper Companies, Inc. is a $11.77B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.

House Trading

U.S. Representative disclosures filed under the STOCK Act.

About this section

U.S. House of Representatives disclosures naming The Cooper Companies, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for The Cooper Companies, Inc.. Coverage tracks The Cooper Companies, Inc. within Medical - Instruments & Supplies (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of The Cooper Companies, Inc.

COO Analysis
Fair
Past2
Growth4
Health4
Profit1
Value1

News

Latest Market News